- The Department of Transportation (DOT) mandates urine drug testing for cannabis under 49 CFR Part 40, with a cutoff level of 50 ng/mL for initial screening and 15 ng/mL for confirmatory GC-MS testing.
- THC metabolites can remain detectable in urine for 3–30 days depending on frequency of use — occasional users typically clear within 3–7 days, while heavy daily users may test positive for 30+ days.
- Federal DOT drug testing rules supersede all state cannabis laws — a positive marijuana result is a federal violation regardless of medical authorization or state legalization status.
- Safety-sensitive transportation workers — including commercial truck drivers, pilots, railway workers, and transit operators — are all subject to mandatory DOT cannabis testing.
- A verified positive DOT drug test requires the employee to be immediately removed from safety-sensitive duties and complete a Return-to-Duty (RTD) process with a Substance Abuse Professional (SAP).
- CBD products are not exempt from DOT testing — cross-contamination with THC in unregulated CBD supplements can trigger a positive result and carries no legal protection under DOT rules.
- The DOT does not recognize or accommodate medical marijuana cards or prescriptions as a valid explanation for a positive drug test result.
What Is DOT Drug Testing and Why Does Cannabis Matter?
The Department of Transportation (DOT) drug testing program is one of the most strictly enforced workplace drug screening systems in the United States. Governed by 49 CFR Part 40, it applies to millions of American workers in safety-sensitive transportation roles. Cannabis — listed as marijuana under federal law — remains a Schedule I controlled substance, and the DOT's position has not changed despite widespread state-level legalization. For any worker subject to DOT oversight, understanding how cannabis testing works is not optional — it is essential to both their career and public safety.
DOT drug testing is separate from general employer drug testing. It carries federal legal weight, standardized procedures, and consequences that can end a career in transportation. The program covers six DOT agencies, each with its own specific regulations, but all following the unified drug testing procedures outlined in Part 40.
Which Federal Agencies Are Covered Under DOT Testing?
The DOT drug testing mandate covers workers regulated by six major agencies. Each agency oversees a different sector of the transportation industry, but all must comply with the same cannabis testing standards established in 49 CFR Part 40. The agencies include:
- Federal Motor Carrier Safety Administration (FMCSA) — Commercial truck and bus drivers holding a Commercial Driver's License (CDL)
- Federal Aviation Administration (FAA) — Pilots, flight crew, air traffic controllers, aircraft dispatchers, and maintenance personnel
- Federal Railroad Administration (FRA) — Locomotive engineers, conductors, train dispatchers, and signal workers
- Federal Transit Administration (FTA) — Bus operators, vehicle operators, controllers, and maintenance workers in public transit
- Pipeline and Hazardous Materials Safety Administration (PHMSA) — Workers operating or maintaining hazardous liquid and gas pipelines
- United States Coast Guard (USCG) — Crew members of commercial vessels navigating U.S. waters
If you work in any of these sectors or are considering employment in transportation, understanding how drug testing works before you start is critical to protecting your livelihood.
What Is the Legal Basis for Testing Despite State Legalization?
Federal law governs DOT-regulated employment. Under the Supremacy Clause of the U.S. Constitution, federal law preempts state law when the two conflict. Because cannabis remains a Schedule I controlled substance under the federal Controlled Substances Act, no state medical marijuana law, adult-use legalization statute, or employer accommodation policy can override the DOT's testing requirements. This means workers in California, Colorado, Michigan, New York — or any of the states where cannabis is legal (see our state-by-state cannabis laws guide) — are still fully subject to federal DOT drug testing rules.
DOT Cannabis Detection Windows: Exact Timeframes by Use Pattern
One of the most misunderstood aspects of DOT drug testing is how long cannabis actually stays detectable in urine. Unlike alcohol, which metabolizes relatively quickly, THC (tetrahydrocannabinol) and its primary metabolite THC-COOH (11-nor-9-carboxy-THC) are fat-soluble compounds that bind to adipose tissue. This means they are released gradually into the bloodstream and excreted in urine over an extended period — far longer than most users realize.
The DOT uses urine testing exclusively for its federally mandated program. Urine testing detects THC-COOH, the inactive metabolite of THC, rather than THC itself. This is important because it means a positive result does not indicate current impairment — only prior use. Despite this distinction, the DOT treats a positive result as a violation regardless of when the cannabis was used.
Detection Windows Based on Frequency of Use
Detection windows vary significantly based on how often a person uses cannabis, their body fat percentage, metabolism rate, hydration levels, and the potency of the cannabis consumed. The following are the most clinically supported estimates:
- Single-use (one-time use): 3–7 days
- Moderate use (2–4 times per week): 10–18 days
- Daily use: 21–30 days
- Heavy chronic use (multiple times daily): 30–90 days, with some cases exceeding 90 days in individuals with high body fat
- Secondhand smoke exposure: Generally not sufficient to trigger a positive at DOT's 50 ng/mL cutoff under normal conditions, though extreme enclosed exposure is debated
High-potency cannabis strains with THC concentrations above 20–30% may result in more prolonged detection windows due to greater metabolite accumulation in tissue. Edibles can also produce longer detection windows compared to smoked flower because of how THC is absorbed and processed through the digestive system.
DOT Cutoff Levels: Initial Screen vs. Confirmatory Test
The DOT uses a two-step testing process with specific concentration thresholds. Understanding these cutoffs is essential because testing positive at the screening level does not automatically constitute a violation — the sample must also be confirmed by a secondary method.
| Test Type | Method | Cutoff Concentration | Purpose |
|---|---|---|---|
| Initial Screen | Immunoassay (IA) | 50 ng/mL THC-COOH | Identifies presumptive positives for further testing |
| Confirmatory Test | Gas Chromatography-Mass Spectrometry (GC-MS) | 15 ng/mL THC-COOH | Definitively confirms or refutes the initial positive |
| Validity Testing | Creatinine, pH, Oxidants | Varies by parameter | Detects Medical Cannabis Guide → Cannabis Effects Guide → |